0001178913-15-001281.txt : 20150421 0001178913-15-001281.hdr.sgml : 20150421 20150421060513 ACCESSION NUMBER: 0001178913-15-001281 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150421 DATE AS OF CHANGE: 20150421 GROUP MEMBERS: ETF'S OF MEITAV DS INVESTMENTS LTD GROUP. GROUP MEMBERS: MUTUAL FUNDS OF MEITAV DS INVESTMENTS LTD GROUP. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Protalix BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001006281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 650643773 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-50118 FILM NUMBER: 15781749 BUSINESS ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 BUSINESS PHONE: 972-4-988-9488 MAIL ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 FORMER COMPANY: FORMER CONFORMED NAME: ORTHODONTIX INC DATE OF NAME CHANGE: 19980422 FORMER COMPANY: FORMER CONFORMED NAME: EMBASSY ACQUISITION CORP DATE OF NAME CHANGE: 19960124 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MEITAV DASH INVESTMENTS LTD CENTRAL INDEX KEY: 0001398346 IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 30 DEREKH SHESHET HA-YAMIM ST. CITY: BENE-BERAQ STATE: L3 ZIP: 5112302 BUSINESS PHONE: 972-3-7903041 MAIL ADDRESS: STREET 1: 30 DEREKH SHESHET HA-YAMIM ST. CITY: BENE-BERAQ STATE: L3 ZIP: 5112302 FORMER COMPANY: FORMER CONFORMED NAME: MEITAV DS INVESTMENTS LTD DATE OF NAME CHANGE: 20131009 FORMER COMPANY: FORMER CONFORMED NAME: DS APEX HOLDINGS LTD DATE OF NAME CHANGE: 20130509 FORMER COMPANY: FORMER CONFORMED NAME: Apex Investments Ltd. DATE OF NAME CHANGE: 20070503 SC 13G 1 zk1516609.htm SC-13G zk1516609.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
(Amendment No. ________)*
 
PROTALIX BIOTHERAPEUTICS, INC.
(Name of Issuer)
 
Ordinary Shares, par value NIS 0.001 per share
(Title of Class of Securities)
 
74365A101
(CUSIP Number)

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
APRIL 19, 2015
(Date of Event which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
¨  Rule 13d-1(b)
 
¨  Rule 13d-1(c)
 
¨  Rule 13d-1(d)
 
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 
 
 
CUSIP No. 74365A101
  
13G
    
 
1.
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Provident funds of Meitav DS Investments LTD group.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)    ¨
(b)    ¨
3.
SEC USE ONLY
 
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israeli
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
1,875,487 Ordinary shares*
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
0
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,875,487 Ordinary shares*
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)    
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
2.01%
12.
TYPE OF REPORTING PERSON (see instructions)
 
CO

* included DS PROVIDENT FUNDS AND PENSION LTD and Meitav Gemel and Pension Funds LTD.

 
 
 
 
CUSIP No. 74365A101
  
13G
    
 
1.
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Mutual funds of Meitav DS Investments LTD group.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)    ¨
(b)    ¨
3.
SEC USE ONLY
 
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israeli
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
1,470,056 Ordinary shares*
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
0
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,470,056 Ordinary shares*
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)    
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
1.57%
12.
TYPE OF REPORTING PERSON (see instructions)
 
CO

* included MEITAV DS MUTUAL FUNDS LTD.
 
 
 
 
 
CUSIP No. 74365A101
  
13G
    
 
1.
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
ETF's of Meitav DS Investments LTD group.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)    ¨
(b)    ¨
3.
SEC USE ONLY
 
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israeli
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 5.
SOLE VOTING POWER
 
0
6.
SHARED VOTING POWER
 
2,890,947 Ordinary shares*
7.
SOLE DISPOSITIVE POWER
 
0
8.
SHARED DISPOSITIVE POWER
 
0
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,890,947 Ordinary shares*
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)    
 
¨
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
3.09%
12.
TYPE OF REPORTING PERSON (see instructions)
 
CO

* included Tachhlit indexes Ltd and Meitav Index Linked Certificates Ltd.

 
 
 
 
Item 1.
 
 
(a)
Name of Issuer
 
PROTALIX BIOTHERAPEUTICS, INC. (hereinafter referred to as the “Issuer”).
 
 
(b)
Address of Issuer’s Principal Executive Offices
 
Snunit 2, P.O.B 455 , Carmiel 20100 , ISRAEL ,
 
Item 2.
 
 
(a)
Name of Person Filing
 
MEITAV DS INVESTMENTS LTD
     
 
(b)
Address of the Principal Office or, if none, residence
 
30 derekh sheshet ha-yamim, Bene-Beraq, israel
     
 
(c)
Citizenship
 
israeli
     
 
(d)
Title of Class of Securities
 
Ordinary Shares, par value NIS 1 per share (the “Ordinary Shares”).
     
 
(e)
CUSIP Number
 
74365A101
 
Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
Not applicable.

 
(a)
¨
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
       
 
(b)
¨
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
       
 
(c)
¨
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
       
 
(d)
¨
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
 
(e)
¨
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
       
 
(f)
¨
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
 
(g)
¨
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
 
(h)
¨
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
 
(i)
¨
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
       
 
(j)
¨
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
       
 
 
 
 
 
Item 4.  Ownership.
 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
 
(a)
Amount beneficially owned:  6,236,490
       
 
(b)
Percent of class:  6.67%
       
 
(c)
Number of shares as to which the person has:  00,000
       
   
(i)
Sole power to vote or to direct the vote  .
       
   
(ii)
Shared power to vote or to direct the vote  .
       
   
(iii)
Sole power to dispose or to direct the disposition of  .
       
   
(iv)
Shared power to dispose or to direct the disposition of  .
 
Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).
 
Item 5.  Ownership of Five Percent or Less of a Class.
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following     ¨.
 
Instruction. Dissolution of a group requires a response to this item.
 
Item 6.  Ownership of More than Five Percent on Behalf of Another Person.
 
 Not applicable.
 
Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
 
Not applicable.
 
Item 8.  Identification and Classification of Members of the Group.
 
Not applicable.
 
Item 9.  Notice of Dissolution of Group.
 
Not applicable.
 
 
 
 
 
Item 10.  Certification.
 
 
(a)
  
The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):
         
     
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
  
         
 
(b)
  
The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):
         
     
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
  
 
 
 
 
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
Teddy Lin, CEO MEITAV DS PROVIDENT FUNDS AND PENSION LTD.
  
     
       
  Date  
     
  Signatute  
 
 
Rafi Niv, CEO MEITAV DS MUTUAL FUND MANAGEMENT (1982) LTD.
  
     
       
  Date  
     
  Signatute  
 
 
Eyal Segal, CEO TACHLIT INDEXES LTD.
  
     
       
  Date  
     
  Signatute